Source: Google NewsPublished on 2021-02-15
Related Articles:
- Monthly Research Review – November 2020 November 30, 2020 At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
- To Vaccinate U.S. Veterans, Health Care Workers Must Cross Mountains, Plains and Tundra February 18, 2021 A Learjet 31 took off before daybreak from Helena Regional Airport in Montana in late January, carrying six Veterans Affairs medical providers and 250 doses of historic cargo cradled in a plug-in cooler designed to minimize breakage. Even in a state where 80-mph speed limits are normal, ground transportation across long distances is risky for the Moderna mRNA-1273 vaccine, which…
- How Telemedicine Can Help You Live Well with Parkinson’s November 28, 2020 Telemedicine is the practice of healthcare in an online format. As video conferencing technology has developed and become more reliable and secure (including being HIPAA-compliant), many physicians and specialists have begun offering their services through video calls in addition to or instead of in-person appointments. Although telemedicine has traditionally been beneficial for people who live in rural areas or for…
- I have Parkinson’s. Should I get a COVID vaccine? February 7, 2021 With several COVID-19 vaccines now approved for emergency use, you and your loved ones may have questions about the vaccine and its safety and efficacy for people with Parkinson’s. Be sure to address any questions and concerns with your doctor, and catch up on the latest research and reports about COVID vaccines and Parkinson’s by exploring these resources. COVID-19 Vaccination…
- COVID-19 and Parkinson’s February 12, 2021 Parkinson Canada is dedicated to the health and wellbeing of all people living with Parkinson’s. We continue to closely monitor information on the COVID-19 pandemic provided by the Public Health Agency of Canada and other public health authorities. What we know today is that the distribution of vaccines is rolling out across Canada in a phased approach that prioritizes access…
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. December 12, 2020 Related ArticlesSafety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020 Dec 08;: Authors: Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Collins AM,…
- Parkinson’s, Flu Shots & You October 11, 2019 October signals the beginning of influenza season, a time when many wonder, “Should I get a flu shot?”. The short answer is, yes, but for people living with Parkinson’s, there can be additional concerns or questions. Let’s take a look at what you and your care team can do to prepare for the 2019-2020 flu season. Who Should Get a…
- UNS’ Investigational Vaccine UB-312 Holds Potential to Prevent Parkinson’s, Other Neurological Diseases, Data Show November 16, 2018 An investigational vaccine being developed by United Neuroscience (UNS) presented several advantages over traditional vaccines to treat progressive disorders, such as Parkinson’s disease, according to preclinical data. The vaccine, called UB-312, was more selective to prevent toxic aggregates of alpha-synuclein in mouse models of the disease. These latest findings were discussed during the Parkinson’s UK Research Conference 2018 held in York, England. The…
- Martin Wishart: a Parkinson’s-friendly Christmas meal December 19, 2019 Scottish Michelin star chef Martin Wishart is currently sailing 3,500 miles across the Atlantic Ocean to raise £40,000 for Parkinson’s research – and celebrate the 20th anniversary of the opening of his Edinburgh restaurant. To mark the occasion, Martin – whose mother lives with Parkinson’s – shares a luxury three-course Christmas recipe which is bursting with nutrition and easy-to-chew First…
- The Source to Salt – Six Marathons in Six Days June 6, 2019 Andrew “Pegs” Pengelly is an inspiring story of courage in the face of adversity. After learning of his diagnosis in his early fifties, Andrew set about constructing a new vision for his life. Part of that vision was a plan of exercise and this year he decided to run over 300km along the River Thames in London. Recently, we asked…
- The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
- Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice. December 19, 2020 Related ArticlesNeuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice. Mol Cell Neurosci. 2020 Dec 15;:103583 Authors: Burgaz S, García C, Gómez-Cañas M, Navarrete C, García-Martín A, Rolland A, Del Río C, Casarejos MJ, Muñoz E, Gonzalo-Consuegra C, Muñoz E, Fernández-Ruiz J Abstract The quinone derivative of the non-psychotropic cannabinoid…
- Parkinson’s Vaccine Triggers Solid Immune Response, Phase 1 Clinical Trial Shows June 15, 2017 AFFiRiS’s new Parkinson’s vaccine, AFFITOPE PD03A, triggered a solid immune response against the alpha-Synuclein (aSyn) protein associated with the disease, according to a Phase 1 clinical trial. Patients also tolerated the therapy well, researchers said. Werner Poewe, a professor at Austria’s Medical University Insbruck, presented the results at the 21stInternational Congress of Parkinson’s Disease and Movement Disorders in Vancouver, Canada, June 4-8. He is part of…
- The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
- Utahns age 16 and older with certain health conditions can make vaccine appointments now, Gov. Cox says - Salt Lake Tribune February 25, 2021 Utahns age 16 and older with certain health conditions can make vaccine appointments now, Gov. Cox says Salt Lake Tribune
- Steps You Can Take to Manage Neurogenic Orthostatic Hypotension July 26, 2017 Written by Jose-Alberto Palma, MD, PhD and Horacio Kaufmann, MD Neurogenic orthostatic hypotension (nOH) is a condition that is part of a larger category called orthostatic hypotension (OH), which is also known as postural hypotension. nOH is caused by dysfunction in the autonomic nervous system and causes people to feel faint when they stand or sit up. Learn more about nOH in the first part…
- Is a vaccine for Parkinson’s disease possible? November 3, 2020 As the world awaits an effective vaccine for SARS-CoV2 (the virus that causes COVID-19), vaccines and vaccination are at the front and center of the news and in our minds. A vaccine is a substance that is introduced into the body in order to stimulate the immune system to provide protection against a particular disease. Did you know that many…
- Is a vaccine for Parkinson’s disease possible? November 3, 2020 As the world awaits an effective vaccine for SARS-CoV2 (the virus that causes COVID-19), vaccines and vaccination are at the front and center of the news and in our minds. A vaccine is a substance that is introduced into the body in order to stimulate the immune system to provide protection against a particular disease. Did you know that many…
- FDA Response Bolsters Affiris’ Plans for Potential Parkinson’s Vaccine Affitope January 29, 2020 The U.S. Food and Drug Administration (FDA) has responded to Affiris‘ pre-investigational new drug (IND) submission regarding a planned Phase 2 clinical trial of the potential Parkinson’s vaccine Affitope (PD01A). After reviewing previous preclinical and clinical data, the FDA answered questions posed by the company and provided guidance related to designing the upcoming trial. Based on that response, Affiris intends to…
- Parkinson's and the Gut - What do we know? What can we do? July 7, 2019 There has been a lot of talk in the last few years about the brain-gut connection, and how Parkinson’s Disease may start in the gut. In this article we’ll explore: What the gut microbiome isThe impact of the gut microbiome on Parkinson’s symptomsThe causes of poor gut healthA 4-step daily routine you can use to jump start your own gut healthWhat is…
- Parkinson's and the Gut - What do we know? What can we do? July 7, 2019 There has been a lot of talk in the last few years about the brain-gut connection, and how Parkinson’s Disease may start in the gut. In this article we’ll explore: What the gut microbiome isThe impact of the gut microbiome on Parkinson’s symptomsThe causes of poor gut healthA 4-step daily routine you can use to jump start your own gut healthWhat is…
- Parkinson's and the Gut - What do we know? What can we do? July 7, 2019 There has been a lot of talk in the last few years about the brain-gut connection, and how Parkinson’s Disease may start in the gut. In this article we’ll explore: What the gut microbiome isThe impact of the gut microbiome on Parkinson’s symptomsThe causes of poor gut healthA 4-step daily routine you can use to jump start your own gut healthWhat is…